OncoMatch/Clinical Trials/NCT06601283
Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer
Is NCT06601283 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2/3 trial studies Vitmain C plus herbal medicine for pancreatic cancer.
Treatment: Vitmain C plus herbal medicine — The purpose of this study is to evaluate the efficacy of low-dose vitamin C plus herbal medicine on improving the quality of life for metastatic pancreatic cancer patients receiving gemcitabine and nab-paclitaxel chemotherapy.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Pancreatic Cancer
Disease stage
Metastatic disease required
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Demographics
Prior therapy
Cannot have received: any anti-tumor therapy
Lab requirements
Blood counts
Hemoglobin (Hgb) ≥ 8 g/dL
Kidney function
Renal insufficiency or dialysis [excluded]
Cardiac function
Cardiovascular disease (Class III or IV heart failure as defined by the New York Heart Association classification, congestive heart failure (CHF), myocardial infarction in the past 6 months, unstable arrhythmia or unstable angina, cerebral infarction within 3 months, etc) [excluded]
Adequate organ performance based on laboratory blood tests. Hemoglobin (Hgb) ≥ 8 g/dL. Renal insufficiency or dialysis [excluded]. Cardiovascular disease (Class III or IV heart failure as defined by the New York Heart Association classification, congestive heart failure (CHF), myocardial infarction in the past 6 months, unstable arrhythmia or unstable angina, cerebral infarction within 3 months, etc) [excluded]
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT06601283 currently recruiting?
Yes, this trial is currently recruiting patients.
Can patients have received prior systemic therapy?
No. This trial requires treatment-naive patients — prior systemic therapy is an exclusion criterion.
Is there an age limit?
Yes. Patients must be 80 years or younger.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages